Influence of calcium concentration in haemodialysis fluid on blood pressure control.

Background: Hypertension is a highly prevalent disorder among patients undergoing haemodialysis. It contributes to greater cardiovascular risk and must be controlled. However, despite dietary measures, haemodialysis regimen optimisation and pharmacological treatment, some patients in our units continue to maintain high blood pressure levels.

Citrate dialysate does not induce oxidative stress or inflammation in vitro as compared to acetate dialysate.

Unlabelled: Increased acetataemia during haemodialysis sessions has been associated with a number of abnormalities, including increased oxidative stress, pro-inflammatory cytokines and nitric oxide synthesis. However, citric acid may play an alternative role to acetate as a dialysate stabiliser given that the effect of citrate on complement and leukocyte activation is different to that of acetate. The purpose of this study was to compare the inflammatory effect in immunocompetent blood cells of acetate dialysate and citrate dialysate.

Follow a recipe to prescribe phosphate during hemodialysis.

The addition of phosphorus (P) to the dialysate (LD) in the form of enema Casen® is common practice in patients with hypophosphatemia. The estimation of the amount to be used and the identification of the problems that may can occur are not well defined. As a result of our work we propose a practical approach of how to proceed to increase phosphate concentration in the hemodialysate.

Factors related with the progression of chronic kidney disease.

Background: Our aims were to determine the rate of progression of chronic kidney disease (CKD) and to identify predictors, with particular emphasis on bone and mineral metabolism.

Methods: Retrospective and observational study including 300 patients with advanced CKD (61.2% males, 33.

Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease.

Objectives: The aim of this study was to analyse the factors influencing chronic kidney disease (CKD) progression in patients with autosomal dominant polycystic kidney disease (ADPKD).

Material And Method: We studied 101 patients (mean age: 43 +/- 17.3 years, 43.

Factors related to the absence of anemia in hemodialysis patients.

Background: A small number of hemodialysis (HD) patients have normal hemoglobin (Hb) levels without the need for erythropoiesis-stimulating agents (ESAs). The factors associated with this condition have been little studied. The objective of this prospective study was to determine these factors in a prevalent population of HD patients.

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Background And Objectives: Hyperuricemia is associated with hypertension, inflammation, renal disease progression, and cardiovascular disease. However, no data are available regarding the effect of allopurinol in patients with chronic kidney disease.

Design, Setting, Participants, & Measurements: We conducted a prospective, randomized trial of 113 patients with estimated GFR (eGFR) <60 ml/min.